Home » All » Stock Forecast » Corvus Pharmaceuticals Inc. Common Stock Forecast

Corvus Pharmaceuticals Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▲ +10.30%Market Cap $1.44B · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$17.49 ▲ +2.03%	Yesterday	$16.99 ▼ -0.85%	Tomorrow's Corvus Pharmaceuticals Inc. Common Stock (CRVS) setup is anchored to $17.14 and targets $17.49 (+2.03%). The near-term read is upside; watch $17.65 / $16.63 because daily realized volatility is about 8.00%.
Tomorrow's Corvus Pharmaceuticals Inc. Common Stock (CRVS) setup is anchored to $17.14 and targets $17.49 (+2.03%). The near-term read is upside; watch $17.65 / $16.63 because daily realized volatility is about 8.00%.
Week	$18.22 ▲ +6.31%	Last Week	$16.69 ▼ -2.65%	The 7-day Corvus Pharmaceuticals Inc. Common Stock model moves from $16.69 to $18.22 (+6.31%). It gives upside momentum context for this stock, so breaks around $17.65 / $16.63 matter more than a single tick.
The 7-day Corvus Pharmaceuticals Inc. Common Stock model moves from $16.69 to $18.22 (+6.31%). It gives upside momentum context for this stock, so breaks around $17.65 / $16.63 matter more than a single tick.
Month	$19.44 ▲ +13.45%	Last Month	$16.17 ▼ -5.65%	The 1-month Corvus Pharmaceuticals Inc. Common Stock target is $19.44 (+13.45%), compared with the live reference near $17.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Corvus Pharmaceuticals Inc. Common Stock target is $19.44 (+13.45%), compared with the live reference near $17.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$21.28 ▲ +24.14%	Last Year	$15.40 ▼ -10.14%	The 1-year Corvus Pharmaceuticals Inc. Common Stock scenario points to $21.28 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Corvus Pharmaceuticals Inc. Common Stock scenario points to $21.28 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$25.57 ▲ +49.20%	5 Years Ago	$13.60 ▼ -20.66%	The 5-year Corvus Pharmaceuticals Inc. Common Stock view is $25.57 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Corvus Pharmaceuticals Inc. Common Stock view is $25.57 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$17.49▲ +2.03%

Yesterday$16.99▼ -0.85%

Tomorrow's Corvus Pharmaceuticals Inc. Common Stock (CRVS) setup is anchored to $17.14 and targets $17.49 (+2.03%). The near-term read is upside; watch $17.65 / $16.63 because daily realized volatility is about 8.00%.

Week$18.22▲ +6.31%

Last Week$16.69▼ -2.65%

The 7-day Corvus Pharmaceuticals Inc. Common Stock model moves from $16.69 to $18.22 (+6.31%). It gives upside momentum context for this stock, so breaks around $17.65 / $16.63 matter more than a single tick.

Month$19.44▲ +13.45%

Last Month$16.17▼ -5.65%

The 1-month Corvus Pharmaceuticals Inc. Common Stock target is $19.44 (+13.45%), compared with the live reference near $17.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$21.28▲ +24.14%

Last Year$15.40▼ -10.14%

The 1-year Corvus Pharmaceuticals Inc. Common Stock scenario points to $21.28 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$25.57▲ +49.20%

5 Years Ago$13.60▼ -20.66%

The 5-year Corvus Pharmaceuticals Inc. Common Stock view is $25.57 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$17.14	Mid
Daily Change	+10.30%	Above
Volatility Cap	20.0%	Mid
Confidence	80%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$17.14

Daily Change+10.30%

Market Cap$1.44B

Sourcenasdaq-screener

Current	$17.14	Daily Change	+10.30%
Market Cap	$1.44B	Source	nasdaq-screener

Support & Resistance Levels

$16.63Support 1

$17.14Current

$17.65Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$17.14Live reference price

Used as the anchor for generated forecast calculations.

Next Month$19.44Model projection+13.45%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

80%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

80%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CRVS today

Bullish Scenario

$18.00

+5.00% from current

Target Price$18.00

ScenarioUpside momentum

Probability62%

Base Scenario

$19.44

+13.45%

Target Price$19.44

ScenarioCapped drift

Probability70%

Bearish Scenario

$16.28

-5.00% from current

Target Price$16.28

ScenarioVolatility drawdown

Probability20%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 79/100

24H drift+2.03%

7D drift+6.31%

30D drift+13.45%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 75/100

1M outlook+13.45%

1Y outlook+24.14%

5Y outlook+49.20%

Frequently Asked Questions

Q What is the Corvus Pharmaceuticals Inc. Common Stock (CRVS) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Corvus Pharmaceuticals Inc. Common Stock is projected near $17.49 versus the current reference around $17.14. That implies a modeled move of +2.03% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CRVS?

The weekly Corvus Pharmaceuticals Inc. Common Stock model points to $18.22, which maps to an expected drift of +6.31% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Corvus Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The Corvus Pharmaceuticals Inc. Common Stock 1-month target is $19.44 (+13.45%), while the 1-year target is $21.28 (+24.14%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Corvus Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The Corvus Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $25.57 with a modeled change of +49.20%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CRVS support and resistance zones right now?

For Corvus Pharmaceuticals Inc. Common Stock, nearest resistance is around $16.63, while nearest support is around $17.65. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Corvus Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.